Literature DB >> 21332515

Triggering receptor expressed on myeloid cells (TREM)-1 participates in Schistosoma mansoni inflammatory responses.

P-C Cheng1, C-N Lin, Y-J Chen, F-S Chang, J C Tsaihong, K-M Lee.   

Abstract

Inflammatory responses to microbial products are amplified by a pathway mediated by triggering a receptor expressed on the myeloid cells (TREM)-1. Relatively a few studies have been performed to investigate the role of TREM-1 in macrophage activation in response to parasitic infection. In this study, we delineate the role of the innate immunoreceptor TREM-1 in the parasite Schistosoma mansoni infection model from early to late (chronic) phases of infection. Flow cytometry analysis revealed gradual increase in the production of TREM-1 protein on CD11b(+) myeloid cells, with maximum production at 5 weeks p.i. Similar results in the pattern of TREM-1 mRNA expressions in splenic CD11b(+) cells from infected mice were obtained by real-time PCR. However, unlike in spleen, the TREM-1 mRNA expression in liver tissue showed no significant increase throughout the infection, including periods of maximum production of parasite eggs. Administration of schistosoma egg homogenate antigen to stimulate J774A.1 cells inhibited TREM-1 expression on the surface, indicating that some substances of the Schistosma eggs may inhibit the expression of TREM-1 on macrophages, lowering the macrophage-mediated inflammatory response of infected hosts.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21332515     DOI: 10.1111/j.1365-3024.2011.01284.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  5 in total

1.  Repetitive Exposure of IL-17 Into the Murine Air Pouch Favors the Recruitment of Inflammatory Monocytes and the Release of IL-16 and TREM-1 in the Inflammatory Fluids.

Authors:  Francesco Maione; Asif Jilani Iqbal; Federica Raucci; Michal Letek; Martina Bauer; Fulvio D'Acquisto
Journal:  Front Immunol       Date:  2018-11-30       Impact factor: 7.561

2.  Potential Utility of Systemic Plasma Biomarkers for Evaluation of Pediatric Schistosomiasis in Western Kenya.

Authors:  Bartholomew N Ondigo; Rachael E Hamilton; Edwin O Magomere; Isaac O Onkanga; Pauline N Mwinzi; Maurice R Odiere; Lisa Ganley-Leal
Journal:  Front Immunol       Date:  2022-05-06       Impact factor: 8.786

Review 3.  Novel ligands and modulators of triggering receptor expressed on myeloid cells receptor family: 2015-2020 updates.

Authors:  Harbinder Singh; Vikrant Rai; Sunil K Nooti; Devendra K Agrawal
Journal:  Expert Opin Ther Pat       Date:  2021-02-08       Impact factor: 6.714

4.  Combined IL-12 Plasmid and Recombinant SjGST Enhance the Protective and Anti-pathology Effect of SjGST DNA Vaccine Against Schistosoma japonicum.

Authors:  Po-Ching Cheng; Ching-Nan Lin; Shih-Yi Peng; Tsung-Fu Kang; Kin-Mu Lee
Journal:  PLoS Negl Trop Dis       Date:  2016-02-18

5.  Antibodies trap tissue migrating helminth larvae and prevent tissue damage by driving IL-4Rα-independent alternative differentiation of macrophages.

Authors:  Julia Esser-von Bieren; Ilaria Mosconi; Romain Guiet; Alessandra Piersgilli; Beatrice Volpe; Fei Chen; William C Gause; Arne Seitz; J Sjef Verbeek; Nicola L Harris
Journal:  PLoS Pathog       Date:  2013-11-14       Impact factor: 6.823

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.